408 related articles for article (PubMed ID: 15313118)
1. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.
Mandegar M; Fung YC; Huang W; Remillard CV; Rubin LJ; Yuan JX
Microvasc Res; 2004 Sep; 68(2):75-103. PubMed ID: 15313118
[TBL] [Abstract][Full Text] [Related]
2. Ion channels in pulmonary arterial hypertension.
Mandegar M; Remillard CV; Yuan JX
Prog Cardiovasc Dis; 2002; 45(2):81-114. PubMed ID: 12411972
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
4. Role of K+ channels in pulmonary hypertension.
Mandegar M; Yuan JX
Vascul Pharmacol; 2002 Jan; 38(1):25-33. PubMed ID: 12378819
[TBL] [Abstract][Full Text] [Related]
5. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
6. Exercise physiology and pulmonary arterial hypertension.
Waxman AB
Prog Cardiovasc Dis; 2012; 55(2):172-9. PubMed ID: 23009913
[TBL] [Abstract][Full Text] [Related]
7. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
8. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
[TBL] [Abstract][Full Text] [Related]
9. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.
Rabinovitch M
J Clin Invest; 2001 Oct; 108(8):1109-11. PubMed ID: 11602617
[No Abstract] [Full Text] [Related]
10. Pathology and pathobiology of pulmonary hypertension.
Guignabert C; Dorfmuller P
Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
13. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
[TBL] [Abstract][Full Text] [Related]
15. The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.
Hayabuchi Y
Pediatr Cardiol; 2017 Jan; 38(1):1-14. PubMed ID: 27826710
[TBL] [Abstract][Full Text] [Related]
16. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
[TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
18. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
[TBL] [Abstract][Full Text] [Related]
20. High altitude pulmonary hypertension: role of K+ and Ca2+ channels.
Remillard CV; Yuan JX
High Alt Med Biol; 2005; 6(2):133-46. PubMed ID: 16060848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
